|Day's Range||6.85 - 7.10|
|52 Week Range||5.20 - 9.32|
|PE Ratio (TTM)||-36.98|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.83|
MIGDAL HA'EMEQ, Israel, June 28, 2017-- Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today announced that Mr. Oren Bryan, will be ...
Categories: Yahoo FinanceGet free summary analysis Enzymotec Ltd. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Enzymotec Ltd. – Sensient Technologies Corporation, Abbott Laboratories and Teva Pharmaceutical Industries Limited Sponsored ADR (SXT-US, ABT-US and TEVA-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)
Enzymotec (ENZY) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.